ADIL Adial Pharmaceuticals Inc

$ADIL Amateurs—what else is there to say? For a year and a half, Carry kept spouting nonsense about Phase 3 for AD04 launching in December 2025, yet he was unable to move the project forward at all. It looks like he just used shareholders' money to fund a long vacation before finally packing his bags and leaving.

$ADIL It’s exhausting watching this stock. Only 3,000 shares trade daily... yet management gets handed tens or even hundreds of thousands of shares, and we still don't know who was hired or even what their role is. The stock might be in the green all day, only to slip into the red right before the market closes. The company’s progress—and any moves it makes—are painfully slow, but when it comes to handing out shares to management, they act instantly. You buy shares with your hard-earned money, only to see someone else get over 300,000 shares for free—without you even knowing their name, let alone their job title.

$ADIL granted a new employee stock option award of 155,446 shares as an inducement under Nasdaq Rule 5635(c)(4).

$ADIL A bunch of amateurs... Instead of trying to attract investors—since hardly anyone is buying their shares—they’re handing shares out to each other like it’s an assembly line!

$ADIL recorded shareholder approval to increase authorized common shares from 100M to 500M and adopt new equity incentive plans.

$ADIL clarifies amendment to its purchase agreement removing penalty provision, changing warrant accounting to regain Nasdaq compliance.